Tigecycline reduces tumorigenesis in colorectal cancer via inhibition of cell proliferation and modulation of immune response
Metadata
Show full item recordAuthor
Ruiz Malagón, Antonio Jesús; Hidalgo García, Laura; Rodríguez Sojo, María Jesús; Molina Tijeras, José Alberto; Díez Echave, Patricia; Vezza, Teresa; Rodríguez Cabezas, María Elena; Rodríguez Nogales, Alba; Gálvez Peralta, Julio JuanEditorial
Elsevier
Materia
Colitis-associated colorectal cancer Tigecycline β-catenin Cytotoxic T lymphocytes Microbiota
Date
2023-04-27Referencia bibliográfica
A.J. Ruiz-Malagón et al. Tigecycline reduces tumorigenesis in colorectal cancer via inhibition of cell proliferation and modulation of immune response. Biomedicine & Pharmacotherapy 163 (2023) 114760[https://doi.org/10.1016/j.biopha.2023.114760]